Compare CSV & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | PRTA |
|---|---|---|
| Founded | 1991 | 2012 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 659.6M | 595.9M |
| IPO Year | 1996 | N/A |
| Metric | CSV | PRTA |
|---|---|---|
| Price | $44.32 | $10.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $59.00 | $18.86 |
| AVG Volume (30 Days) | 67.0K | ★ 611.9K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ 3.09 | N/A |
| Revenue | ★ $409,658,000.00 | $11,786,000.00 |
| Revenue This Year | $3.81 | N/A |
| Revenue Next Year | $3.37 | $819.08 |
| P/E Ratio | $14.01 | ★ N/A |
| Revenue Growth | ★ 1.07 | N/A |
| 52 Week Low | $35.51 | $4.32 |
| 52 Week High | $49.41 | $17.66 |
| Indicator | CSV | PRTA |
|---|---|---|
| Relative Strength Index (RSI) | 60.72 | 48.93 |
| Support Level | $41.50 | $9.69 |
| Resistance Level | $43.49 | $10.50 |
| Average True Range (ATR) | 0.90 | 0.56 |
| MACD | 0.26 | -0.06 |
| Stochastic Oscillator | 79.69 | 34.04 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise; and enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.